Showing results (221-230 of 31,336) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|January 28, 2009
Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylaseKeith Clinch, Gary B Evans, Richard F G Fröhlich, et al.Journal of Medicinal Chemistry|August 5, 2010
Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profileChao-Cheng Chiang, Yu-Hsiang Lin, Shu Fu Lin, et al.Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.Journal of Medicinal Chemistry|October 13, 2010
Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugsSumith A Kularatne, Chelvam Venkatesh, Hari-Krishna R Santhapuram, et al.Journal of Medicinal Chemistry|September 16, 2010
Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptorsMarika Skultety, Harald Hübner, Stefan Löber, et al.Journal of Medicinal Chemistry|November 1, 1978
Potential bis-alkylating agents for cancer chemotherapy. Approaches to the synthesis of 2-sulfonyl-1,4-bis(methanesulfonoxy)butanesJ M WilburJournal of Medicinal Chemistry|November 1, 1978
Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5--27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptideM Bodansky, S Natarajan, J D Gardner, et al.Journal of Medicinal Chemistry|March 12, 2011
Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeuticsKrishnendu Pal, SubrataKumar Pore, Sutapa Sinha, et al.Journal of Medicinal Chemistry|April 9, 2011
Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulatorsMin-Jun Li, Harry M Greenblatt, Orly Dym, et al.Journal of Medicinal Chemistry|March 23, 2011
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitorsMarion Flipo, Matthieu Desroses, Nathalie Lecat-Guillet, et al.Pageof 3,134